Open AccessBiomarkers of left atrial overload in obese and nonobese patients with atrial fibrillation qualified for electrical cardioversion
Author(s) -
Małgorzata Cichoń,
Magdalena MiziaSzubryt,
Magdalena Olszanecka-Glinianowicz,
Maria Bożentowicz-Wikarek,
Aleksander Owczarek,
Rafał Michalik,
Katarzyna Mizia-Stec
Publication year - 2021
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.15673
Subject(s) - medicine , atrial fibrillation , copeptin , cardiology , cardioversion , pressure overload , electrical cardioversion , natriuretic peptide , heart failure , cardiac hypertrophy , vasopressin
Biomarkers of left atrial (LA) overload are considered factors affecting the efficacy of atrial fibrillation (AF) treatment. Increasing obesity rates contribute to a growing number of obese patients qualified for electrical cardioversion (CVE).Biomarkers of left atrial (LA) overload are considered as factors influencing efficacy of atrial fibrillation (AF) treatment. The increasing rate of obesity contributes to obese patients constituting a significant group of subjects qualified to electrical cardioversion (CVE).